GO:0036505 prosaposin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036505 prosaposin receptor activity is a molecular function defined as combining with prosaposin to initiate a change in cell activity [QuickGO].
• Prosaposin is the glycoprotein precursor of four saposins (A, B, C, D) and can act as a secreted ligand for specific receptors.
• The best-characterized prosaposin receptor is GPR37L1, a G-protein-coupled receptor that modulates Ptch1 trafficking and Shh signaling in cerebellar astrocytes.
• Prosaposin receptor activity is linked to G-protein signaling, ERK activation, and sphingosine kinase pathways [1,4].
• Dysregulation of prosaposin receptor activity has been implicated in neural cell survival, apoptosis, and ischemic brain injury [4,7].
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the causal roles of prosaposin receptors in disease [3,4].
Description
Prosaposin receptor activity (GO:0036505) is a molecular function that mediates cellular responses to the secreted glycoprotein prosaposin. Prosaposin is the precursor of four saposins (A, B, C, and D) and can also act as a ligand for specific cell surface receptors. The term describes the binding of prosaposin to its receptor, which triggers intracellular signaling cascades and changes in cell behavior. This activity is critical for understanding how extracellular prosaposin communicates with cells in the nervous system and beyond. The first evidence for a prosaposin receptor came from studies showing that prosaposin binding is associated with G-proteins, suggesting a classical GPCR-like mechanism. Since then, GPR37L1 has been identified as a prosaposin receptor that regulates Ptch1 trafficking and Shh production in cerebellar astrocytes. Prosaposin receptor activity is also linked to cell cycle progression and prevention of apoptosis in PC12 cells through ERK and sphingosine kinase activation. These findings highlight the importance of this GO term in neurobiology, cell signaling, and disease mechanisms. Researchers studying prosaposin receptor activity need reliable models to investigate its role in health and disease. This article provides a comprehensive overview of the definition, mechanism, key genes, and research methods for GO:0036505.
prosaposin receptor activity At A Glance
| GO ID | GO:0036505 |
|---|---|
| GO term | prosaposin receptor activity |
| Ontology | molecular_function |
| Synonym | prosaposin-activated receptor activity |
| Major function | Binding to prosaposin to initiate a change in cell activity |
| Definition source | QuickGO |
| Related receptor | GPR37L1 (prosaposin receptor) |
| Signaling pathway | G-protein-associated receptor signaling |
| Cellular context | Neural cells, astrocytes, PC12 cells [3,4] |
What Is GO:0036505?
Prosaposin receptor activity (GO:0036505) is defined as the molecular function of combining with prosaposin to initiate a change in cell activity. Prosaposin is the glycoprotein precursor of four cleavage products, saposins A, B, C, and D. This activity is synonymous with prosaposin-activated receptor activity. It represents the initial step in a signaling pathway where extracellular prosaposin binds to a specific receptor on the cell surface, leading to intracellular signal transduction and cellular responses.
Why Is prosaposin receptor activity Important in Cell Biology?
Prosaposin receptor activity is important because it mediates the pleiotropic effects of prosaposin, a secreted protein with neurotrophic and neuroprotective functions. This activity is involved in cell survival, proliferation, and differentiation, particularly in the nervous system [4,7]. Understanding this molecular function can reveal how prosaposin communicates with cells and how dysregulation contributes to diseases such as neurodegeneration and cancer.
• Regulates cell cycle progression and prevents apoptosis in neural cells.
• Modulates Shh signaling and cell proliferation in cerebellar astrocytes.
• Linked to G-protein signaling and ERK activation [1,4].
• Involved in sphingosine kinase activation and sphingolipid metabolism.
• Implicated in ischemic brain injury and retrograde thalamic degeneration.
• Potential target for neuroprotective therapies.
• Relevant to megalencephalic leukoencephalopathy and glial cell function.
• Provides a mechanism for prosaposin-mediated cell-cell communication.
• May influence macrophage responses to viral infection.
• Offers a paradigm for studying GPCR signaling by glycoprotein ligands.
What Happens During prosaposin receptor activity?
Ligand Binding and Receptor Activation
In simple terms: Prosaposin binds to its receptor on the cell surface, like a key fitting into a lock.
Prosaposin, the glycoprotein precursor of saposins A-D, is secreted and can bind to specific receptors. The first evidence for a prosaposin receptor showed that binding is associated with G-proteins, indicating a GPCR-like mechanism. GPR37L1 has been identified as a prosaposin receptor that interacts with prosaposin to modulate downstream signaling.
G-Protein Coupling and Intracellular Signaling
In simple terms: Once prosaposin binds, the receptor activates G-proteins inside the cell, starting a signaling chain.
Prosaposin receptor activity is linked to G-protein association, as demonstrated by co-immunoprecipitation and GTP-binding assays. This activation leads to downstream events such as ERK phosphorylation and sphingosine kinase activation, which are critical for cell cycle entry and survival.
Modulation of Ptch1 Trafficking and Shh Signaling
In simple terms: The prosaposin receptor helps move Ptch1 and influences Shh signaling, affecting cell proliferation.
In cerebellar primary astrocytes, Gpr37l1 (prosaposin receptor) regulates Ptch1 trafficking and Shh production, thereby influencing cell proliferation. This demonstrates a role for prosaposin receptor activity in developmental signaling pathways.
Interaction with Gangliosides and Membrane Microdomains
In simple terms: Prosaposin can team up with GM3 ganglioside on the cell membrane, forming a complex that may affect receptor function.
Prosaposin colocalizes and forms a complex with monosialoganglioside GM3 in neural cells. This interaction may modulate prosaposin receptor activity by concentrating prosaposin at specific membrane domains.
Cellular Outcomes: Survival, Proliferation, and Neuroprotection
In simple terms: Activation of the prosaposin receptor can help cells survive, divide, and protect neurons.
Prosaposin treatment induces PC12 cell entry into S phase and prevents apoptosis via ERK and sphingosine kinase activation. An 18-mer prosaposin peptide ameliorates place navigation disability and cortical infarction in rats, suggesting neuroprotective effects.
Key Genes Involved in GO:0036505 prosaposin receptor activity
The following genes and proteins are directly involved in prosaposin receptor activity or its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PSAP | Encodes prosaposin, the ligand for the receptor | Ligand source; knockout reduces receptor activation |
| GPR37L1 | Prosaposin receptor; GPCR that modulates Ptch1 and Shh | Knockout alters astrocyte proliferation |
| GPR37 | Related orphan GPCR; may interact with prosaposin | Potential alternative receptor; interactome studies |
| GNAI1 | G-protein alpha subunit; mediates GPCR signaling | Involved in prosaposin receptor G-protein coupling |
| MAPK1 | ERK2; downstream kinase in prosaposin signaling | Phosphorylation readout for receptor activation |
| MAPK3 | ERK1; downstream kinase in prosaposin signaling | Phosphorylation readout for receptor activation |
| SPHK1 | Sphingosine kinase 1; activated by prosaposin | Mediates anti-apoptotic effects |
| PTCH1 | Patched 1; trafficking regulated by Gpr37l1 | Shh signaling modulation |
| SHH | Sonic hedgehog; production influenced by Gpr37l1 | Astrocyte proliferation |
| GM3 | Monosialoganglioside; forms complex with prosaposin | Membrane microdomain localization |
| GLIALCAM | Megalencephalic leukoencephalopathy protein; interacts with GPRC5B/GPR37L1 | Interactome link to disease |
| GPRC5B | GPCR identified in GlialCAM interactome | May modulate prosaposin receptor complexes |
| CLCN2 | Chloride channel; associated with leukoencephalopathy | Potential downstream target |
| MPZ | Myelin protein zero; related to glial function | Indirect link to prosaposin receptor biology |
| ASFV | African swine fever virus; modulates host gene expression | Infection model for macrophage signaling |
| CD68 | Macrophage marker; expression changes in ASFV infection | Inflammation context |
| TLR4 | Toll-like receptor; innate immunity | Potential crosstalk with prosaposin signaling |
| NPC1 | Niemann-Pick C1; cholesterol trafficking | Saposin-related lipid metabolism |
How Is prosaposin receptor activity Regulated?
Prosaposin receptor activity is regulated at multiple levels. The availability of prosaposin ligand is controlled by its secretion and cleavage into saposins. Receptor expression levels, such as GPR37L1, can be modulated by transcriptional and post-transcriptional mechanisms. G-protein coupling and downstream effectors like ERK and sphingosine kinase provide additional regulatory nodes. Ganglioside GM3 may regulate receptor localization and activity by forming complexes with prosaposin. Furthermore, interactions with other GPCRs like GPRC5B could modulate signaling.
prosaposin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR37L1 | Megalencephalic leukoencephalopathy | Knockout astrocytes [2,3] |
| PSAP | Neurodegeneration, prosaposin deficiency | Knockout mice |
| SPHK1 | Apoptosis resistance, cancer | Overexpression in PC12 cells |
| PTCH1 | Shh signaling, medulloblastoma | Knock-in reporters |
| GM3 | Gangliosidosis, membrane signaling | Point mutation in GM3 synthase |
Neurodegeneration and Ischemic Brain Injury
Prosaposin receptor activity is neuroprotective. An 18-mer prosaposin peptide ameliorates place navigation disability, cortical infarction, and retrograde thalamic degeneration in rats with focal cerebral ischemia. This suggests that activating prosaposin receptors could be therapeutic for stroke and neurodegenerative conditions.
Megalencephalic Leukoencephalopathy
GPR37L1, a prosaposin receptor, was identified in the GlialCAM interactome, linking it to megalencephalic leukoencephalopathy. Disruption of this interaction may contribute to white matter disease.
Cancer and Cell Proliferation
Prosaposin receptor activity induces cell cycle entry and prevents apoptosis in PC12 cells via ERK and sphingosine kinase. Dysregulation could promote aberrant proliferation in tumors, making it a potential cancer target.
Viral Infection and Macrophage Responses
African swine fever virus infection alters gene expression in macrophages, including potential modulation of prosaposin receptor pathways. This highlights a role in host-pathogen interactions.
From prosaposin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GPR37L1 mediate prosaposin-induced ERK activation? | GPR37L1 knockout cells |
| What is the role of prosaposin receptor in cell cycle? | PSAP overexpression in PC12 cells |
| How does prosaposin receptor regulate Shh signaling? | Gpr37l1 knockout astrocytes |
| Does prosaposin binding require GM3? | GM3 synthase knockout cells |
| Can prosaposin peptide protect against stroke? | In vivo rat ischemia model |
| What is the interactome of prosaposin receptor? | Tagged knock-in of GPR37L1 |
How to Study the prosaposin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Direct prosaposin-receptor interaction | Receptor affinity |
| GTPgammaS binding | G-protein activation | GPCR coupling |
| Phospho-ERK Western blot | ERK activation | Downstream signaling |
| Sphingosine kinase assay | Sphingosine kinase activity | Lipid signaling |
| Co-immunoprecipitation | Protein-protein interactions | Receptor complex formation |
| Immunofluorescence | Cellular localization | Colocalization with GM3 |
| Shh reporter assay | Shh production | Astrocyte signaling |
| Behavioral tests | Neuroprotection in vivo | Stroke models |
Ligand Binding Assays
Radiolabeled or fluorescently labeled prosaposin can be used to measure binding to receptors on cell membranes. This directly assesses prosaposin receptor activity.
G-Protein Activation Assays
GTPgammaS binding or cAMP measurements can detect G-protein coupling following prosaposin stimulation, as initially shown for the prosaposin receptor.
Downstream Signaling Readouts
Phospho-ERK and sphingosine kinase activity assays are used to monitor prosaposin receptor activation and its downstream effects.
Imaging and Colocalization
Immunofluorescence and co-immunoprecipitation can visualize prosaposin-receptor complexes and colocalization with GM3.
How CRISPR Can Be Used to Study GO:0036505 prosaposin receptor activity
Knockout
CRISPR knockout of GPR37L1 or PSAP can abolish prosaposin receptor activity, allowing researchers to study loss-of-function phenotypes in astrocytes, PC12 cells, or animal models [3,4].
Point Mutation
Introducing point mutations in the prosaposin binding pocket of GPR37L1 can dissect residues critical for ligand binding and G-protein coupling, as suggested by the G-protein association of the receptor.
Knock-in
Knock-in of tagged GPR37L1 (e.g., HA or GFP) enables proteomic and imaging studies to identify interacting partners and trafficking dynamics.
Overexpression
Overexpression of prosaposin or GPR37L1 in cell lines can enhance receptor activity and downstream signaling, useful for gain-of-function studies.
How EDITGENE Supports prosaposin receptor activity Research
Researchers studying prosaposin receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, cell survival, or disease phenotypes. EDITGENE provides custom CRISPR cell models to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for prosaposin receptor activity research.
Frequently Asked Questions About prosaposin receptor activity
What is prosaposin receptor activity?
Prosaposin receptor activity (GO:0036505) is the molecular function of binding to prosaposin to initiate a change in cell activity, often through G-protein-coupled receptors like GPR37L1 [1,3].
What genes are involved in prosaposin receptor activity?
Key genes include PSAP (encoding prosaposin), GPR37L1 (a prosaposin receptor), GPR37, and downstream effectors like MAPK1/3 and SPHK1 [1,3,4].
Which receptor binds prosaposin?
GPR37L1 has been identified as a prosaposin receptor that regulates Ptch1 trafficking and Shh signaling. GPR37 is a related orphan receptor.
What is the role of prosaposin in cell signaling?
Prosaposin binding to its receptor activates G-proteins, ERK, and sphingosine kinase, promoting cell cycle entry and preventing apoptosis [1,4].
How is prosaposin receptor activity studied?
Common methods include radioligand binding, GTPgammaS binding, phospho-ERK Western blot, and Shh reporter assays [1,3,4].
Is prosaposin receptor activity linked to disease?
Yes, it is implicated in neurodegeneration, ischemic brain injury, megalencephalic leukoencephalopathy, and cancer [2,4,7].
What is the synonym for GO:0036505?
The synonym is prosaposin-activated receptor activity.
Can CRISPR be used to study prosaposin receptor activity?
Yes, CRISPR knockout, knock-in, and overexpression models are valuable for dissecting gene function in this pathway [3,4].
What cell types express prosaposin receptors?
Prosaposin receptors are expressed in neural cells, cerebellar astrocytes, and PC12 cells, among others [3,4].
What are the downstream effects of prosaposin receptor activation?
Activation leads to ERK phosphorylation, sphingosine kinase activation, cell cycle progression, and neuroprotection [4,7].
Conclusion
Prosaposin receptor activity (GO:0036505) is a critical molecular function that mediates the diverse biological effects of prosaposin. Through receptors like GPR37L1, it regulates cell survival, proliferation, and signaling pathways such as Shh and ERK. Its involvement in neurodegeneration, leukoencephalopathy, and cancer underscores its therapeutic potential. Continued research using CRISPR models will further elucidate its mechanisms and disease relevance.
References
- 1. Hiraiwa M et al.. 1997. Prosaposin receptor: evidence for a G-protein-associated receptor.. Biochem Biophys Res Commun 240(2):415-8 PMID: 9388493
- 2. Alonso-Gardón M et al.. 2021. Identification of the GlialCAM interactome: the G protein-coupled receptors GPRC5B and GPR37L1 modulate megalencephalic leukoencephalopathy proteins.. Hum Mol Genet 30(17):1649-1665 PMID: 34100078
- 3. La Sala G et al.. 2020. Gpr37l1/prosaposin receptor regulates Ptch1 trafficking, Shh production, and cell proliferation in cerebellar primary astrocytes.. J Neurosci Res PMID: 33350496
- 4. Misasi R et al.. 2001. Prosaposin treatment induces PC12 entry in the S phase of the cell cycle and prevents apoptosis: activation of ERKs and sphingosine kinase.. FASEB J 15(2):467-74 PMID: 11156962
- 5. Misasi R et al.. 1998. Colocalization and complex formation between prosaposin and monosialoganglioside GM3 in neural cells.. J Neurochem 71(6):2313-21 PMID: 9832129
- 6. Yang B et al.. 2021. Mechanism of interaction between virus and host is inferred from the changes of gene expression in macrophages infected with African swine fever virus CN/GS/2018 strain.. Virol J 18(1):170 PMID: 34412678
- 7. Igase K et al.. 1999. An 18-mer peptide fragment of prosaposin ameliorates place navigation disability, cortical infarction, and retrograde thalamic degeneration in rats with focal cerebral ischemia.. J Cereb Blood Flow Metab 19(3):298-306 PMID: 10078882
